Published in Arkh Patol on January 01, 1978
Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis (2012) 0.93
[Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region]. Probl Tuberk Bolezn Legk (2005) 0.84
Detection of rifampicin-resistant Mycobacterium tuberculosis strains by hybridization and polymerase chain reaction on a specialized TB-microchip. Bull Exp Biol Med (2001) 0.81
[New organizational forms of antituberculosis care under present conditions. Results and experience exchange of work in pilot regions. Scientific-and-Practical Conference (Moscow, September 25-27, 2002)]. Probl Tuberk (2003) 0.80
[Systemic transplantation of autologous mesenchymal stem cells of the bone marrow in the treatment of patients with multidrug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.79
[Preponderance of Mycobacterium tuberculosis strains of the family Beijing and risk factors of their transmission in the Samara Region]. Probl Tuberk Bolezn Legk (2006) 0.77
New 5-modified pyrimidine nucleoside inhibitors of mycobacterial growth. Acta Naturae (2010) 0.75
[On the morphological diagnosis of drug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.75
[Diagnosis and treatment of fibrosing alveolitis]. Ter Arkh (1987) 0.75
[Lung macrophages (review of the literature)]. Probl Tuberk (1980) 0.75
[Current views of tuberculosis inflammation]. Probl Tuberk (2003) 0.75
[Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro]. Probl Tuberk Bolezn Legk (2006) 0.75
[Monitoring detection and treatment of new patients with pulmonary tuberculosis]. Vestn Ross Akad Med Nauk (2010) 0.75
[Morphology of exogenous allergic alveolitis]. Sov Med (1986) 0.75
[Morphological diagnosis of tuberculosis and some disseminated diseases of the lungs]. Probl Tuberk (2001) 0.75
[Comparison between the morphofunctional state of the thymus and peripheral organs of the immune system in tuberculosis]. Probl Tuberk (1984) 0.75
[Intra-dental route of experimental tuberculosis infection]. Probl Tuberk (1991) 0.75
[Postmortem diagnosis of the major forms of tuberculosis (according to autopsy data)]. Probl Tuberk Bolezn Legk (2008) 0.75
[Ultrastructure of the neuroepithelial cells of the respiratory portion of the lungs in experimental inflammatory diseases of the lungs]. Arkh Patol (1979) 0.75
[Psychoemotional changes in patients with pulmonary tuberculosis during therapy using psychological and neuropsychological methods]. Probl Tuberk Bolezn Legk (2009) 0.75
[Electron microscopic and histochemical study of the cells of the alveolar epithelia in experimental tuberculosis]. Probl Tuberk (1967) 0.75
[The achievements and the way of innovative development of phthisiology]. Vestn Ross Akad Med Nauk (2012) 0.75
[Modern concepts of the structure of Mycobacterium tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Main results of researches at the institutions of the Russian Academy of Medical Sciences in 2001-2003]. Probl Tuberk Bolezn Legk (2004) 0.75
[Electron microscopic and histochemical study of experimental lipid pneumonia]. Probl Tuberk (1978) 0.75
[The morphofunctional heterogeneity of the alveolar macrophages in disseminated pulmonary tuberculosis]. Probl Tuberk (1996) 0.75
[Bronchoalveolar lavage in assessing the structural integrity of surfactant in pulmonary tuberculosis]. Probl Tuberk (1988) 0.75
[Experience with small-volume plasmapheresis used in the correction of hemostatic disorders in patients with progressive destructive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2007) 0.75
[Comparison of radionuclide studies with pleural morphological changes in patients with tuberculosis pleurisy]. Probl Tuberk Bolezn Legk (2009) 0.75
[Current methods of diagnosis of sarcoidosis of respiratory organs]. Probl Tuberk (1982) 0.75
[Effects of immunomodulator leukinferon on the course of experimental tuberculosis]. Probl Tuberk (2003) 0.75
[Morphological signs of ineffective chemotherapy for experimental destructive pulmonary tuberculosis]. Probl Tuberk (1998) 0.75
[Functional and roentgeno-morphological characteristics of peripheral bronchi in sarcoidosis of the lungs and intrathoracic lymph nodes]. Probl Tuberk (1988) 0.75
[Assessment of the production of surfactant by type II alveolocytes during chemotherapy of experimental pulmonary tuberculosis]. Probl Tuberk (1986) 0.75
[Medico-biological aspects of chronic alcoholism and problems of phthisiology]. Probl Tuberk (1987) 0.75
[Specific features of the macrophage formula of bronchoalveolar lavage in patients with destructive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2003) 0.75
[The tissue and cellular reactions of the lung in drug-resistant tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[The results of work and experience of the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, in the pilot areas in controlling, detecting, and treating tuberculosis (a cohort analysis)]. Probl Tuberk Bolezn Legk (2006) 0.75
[Pleural cytopathology in the chemotherapy of destructive tuberculosis in an experiment]. Probl Tuberk (1988) 0.75
[The pathoanatomical,diagnosis of progressive forms of pulmonary tuberculosis in relation to the new clinical classification]. Probl Tuberk (1996) 0.75
[Critical state medicine. Surfactant therapy of adult respiratory distress syndrome (results of multicenter studies)]. Vestn Ross Akad Med Nauk (2001) 0.75
[Analyzing the drug resistance of Mycobacterium tuberculosis in Russia's experimental areas introducing the WHO tuberculosis control programme]. Probl Tuberk (2002) 0.75
[Electron microscopic study of the pathogenesis of experimental lipid pneumonia]. Biull Eksp Biol Med (1980) 0.75
[Prof. V. G. Shtefko--outstanding scientist and phthisiologist]. Probl Tuberk (1993) 0.75
[Method of double embedding of tissue in paraplast-piccolyte]. Arkh Patol (1983) 0.75
[Functional morphology of the lungs in patients with tuberculosis and diabetes mellitus]. Probl Tuberk (1992) 0.75
[Leukinferon in combined therapy for acute pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Electron-microscopy study of the lungs in acute experimental respiratory insufficiency treated by extracorporeal membrane oxygenation]. Probl Tuberk (1984) 0.75
[The morphofunctional state of the surfactant system in pulmonary tuberculosis]. Probl Tuberk (2003) 0.75
[Formation of the rate of mortality due to active tuberculosis in the areas in the charge of the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences]. Probl Tuberk Bolezn Legk (2005) 0.75
[The role of physician teams in the complex prevention of parasitoses]. Med Parazitol (Mosk) (1998) 0.75
[Features of morphological reactions in caseous pneumonia]. Probl Tuberk (2001) 0.75
[Electron microscopic demonstration of pulmonary surfactant proteins using procion brilliant blue H5GS]. Biull Eksp Biol Med (1981) 0.75
[Effectiveness of the treatment of experimental destructive pulmonary tuberculosis with antibacterial drugs combined with levamisole and diucifon]. Probl Tuberk (1984) 0.75
[Connective tissue function and fibril formation processes in fibrous-cavernous pulmonary tuberculosis]. Arkh Patol (1985) 0.75
[Tuberculosis and the work of the Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, in the years of the Great Patriotic War]. Probl Tuberk Bolezn Legk (2006) 0.75
[Structure of Mycobacterium tuberculosis based on electron microscopic data]. Probl Tuberk (1982) 0.75
[The XXIX International conference on tuberculosis and pulmonary diseases. (IUATLD/UICTMR) Global Congress on lung health. Bangkok, Thailand, November 23-26, 1998]. Probl Tuberk (1999) 0.75
[Ultrastructural and metabolic changes in the lungs in experimental tuberculosis]. Probl Tuberk (1981) 0.75
[Electric stimulation of the diaphragm in the treatment of acute respiratory insufficiency]. Probl Tuberk (1982) 0.75
[Effect of ultrasonic inhalations of antitubercular preparations on the air-blood barrier of the lung]. Probl Tuberk (1985) 0.75
[Monitoring of the detection of new pulmonary tuberculosis cases and the efficiency of their treatment in the area supervised by the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences]. Probl Tuberk Bolezn Legk (2008) 0.75
[Morphological signs of acute lung lesion in patients with caseous pneumonia]. Probl Tuberk Bolezn Legk (2006) 0.75
[Role of pathomorphological studies in the diagnosis of disseminated lung diseases]. Probl Tuberk (1986) 0.75
[Up-to-date technologies in preoperative preparation and postoperative period in patients with progressive destructive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.75
[The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis]. Probl Tuberk (2000) 0.75
[Histochemical and ultrastructural characteristics of the lymphoid and plasma cells in experimental tuberculous granuloma]. Probl Tuberk (1981) 0.75
[Morphofunctional status of the lungs in extrinsic allergic alveolitis]. Arkh Patol (1986) 0.75
[Morphological characteristics of reparative process in tuberculous inflammation]. Vestn Ross Akad Med Nauk (1995) 0.75
[The modelling of the extrinsic allergic alveolitis of woodworkers]. Lik Sprava (1992) 0.75
[Morpho-functional changes of surfactant system in pulmonary tuberculosis]. Vestn Ross Akad Med Nauk (2000) 0.75
[The clinical and morphological features of the course of tuberculosis in HIV infection]. Probl Tuberk Bolezn Legk (2008) 0.75
[Tuberculosis thanatogenesis and pathoanatomy of caseous pneumonia]. Probl Tuberk (1996) 0.75
[Pulmonary scintigraphy in evaluating the efficiency of surfactant therapy in the complex treatment of patients with destructive pulmonary tuberculosis]. Vestn Rentgenol Radiol (2007) 0.75
[The quality of bacteriological detection and determination of drug sensitivity of Mycobacterium tuberculosis by the participants of the External Clinical Laboratory Study Quality Assessment made by the Federal System in 2002-2003]. Probl Tuberk Bolezn Legk (2005) 0.75
[Impact of phthisiosurgery on the development of morphological studies of the lung]. Probl Tuberk Bolezn Legk (2006) 0.75
[The state-of-the-art of Russia's Laboratory Tuberculosis Diagnosis Service: basic problems and ways of their overcoming]. Probl Tuberk Bolezn Legk (2006) 0.75
[Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.75
[Pulmonary histiocytosis X]. Probl Tuberk (1990) 0.75
[Acquired immunodeficiency syndrome (its clinico-morphological aspects)]. Probl Tuberk (1987) 0.75
[Morphological manifestations of secondary immunodeficiency]. Probl Tuberk (1990) 0.75
[Central Institute of Tuberculosis]. Vestn Ross Akad Med Nauk (1998) 0.75
[Lymphoid cell ultrastructure in experimental tuberculous granuloma]. Biull Eksp Biol Med (1980) 0.75
[Pathomorphological changes in the lung in tuberculosis patients died from HIV infection at the stage of AIDS]. Arkh Patol (2007) 0.75
[Electron microscopic study of the lungs in tuberculosis and nonspecific inflammation]. Probl Tuberk (1982) 0.75
[AIDS and its manifestations in the form of tuberculosis and other pathology of the lungs]. Probl Tuberk (1989) 0.75
[Small pulmonary alveolar cells (type I pneumocytes)]. Arkh Anat Gistol Embriol (1974) 0.75
[The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected]. Probl Tuberk Bolezn Legk (2005) 0.75
[Effects of mixture of fermented whey SGOL-1-40 ("Sgidolac") and sterilized milk on the course of experimental tuberculosis]. Vopr Pitan (2000) 0.75
[Hemosorption and extracorporeal membrane oxygenation of the blood in the therapy of patients with chronic lung diseases]. Probl Tuberk (1986) 0.75
[Tuberculous periodontitis]. Probl Tuberk (1993) 0.75
[Trend in the gender-age structure of tuberculosis morbidity over 10 years in the Russian Federation's areas followed up by the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences]. Probl Tuberk Bolezn Legk (2006) 0.75
[Scanning electron microscopy in the study of experimental pulmonary tuberculosis]. Probl Tuberk (1977) 0.75
[Cellular technologies in therapy for chronic multidrug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.75
[Structural changes in the thymus in experimental tuberculosis]. Biull Eksp Biol Med (1982) 0.75
[Bronchoalveolar lavage in patients with pulmonary tuberculosis]. Probl Tuberk (1984) 0.75
[Preparation and study of Langmuir films of nucleic acid and octadecylamine complexes]. Biofizika (1993) 0.75
[Main results and prospects of the activities of a WHO collaborating tuberculosis-combating center in the Russian Federation]. Probl Tuberk Bolezn Legk (2004) 0.75
[Effect of surfactant-BL on ventilation and gas exchange function in patients with destructive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.75
[Clinical-morphological criteria of drug-induced hepatitis in pulmonary tuberculosis patients]. Probl Tuberk (1991) 0.75